[Targeted therapy of neoplasms and pharmacopathology].
Zhu
Xiong-Zeng
XZ
D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D018951:Antigens, CD20 / Q000187:drug effects / Q000378:metabolism; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D016503:Drug Delivery Systems / Q000379:methods*; D016044:Fusion Proteins, bcr-abl / Q000187:drug effects / Q000378:metabolism; D015316:Genetic Therapy; D006801:Humans; D009369:Neoplasms / Q000378:metabolism / Q000473:pathology / Q000628:therapy*; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000187:drug effects / Q000378:metabolism
D000911:Antibodies, Monoclonal; D018951:Antigens, CD20; D000970:Antineoplastic Agents; D016044:Fusion Proteins, bcr-abl; D018719:Erb-b2 Receptor Tyrosine Kinases